Varian Medical Systems, Inc. Announces the Appointment of Anat Ashkenazi to the Board, Effective December 1, 2018
November 20, 2018 at 06:03 am EST
Varian Medical Systems, Inc. announced the appointment of Anat Ashkenazi, Senior Vice President, Controller and Chief Financial Officer, Lilly Research Labs, to the Board effective December 1, 2018. The size of the Board of Directors was increased to ten, effective December 1, 2018, in connection with Ms. Ashkenazi’s appointment. The Board also appointed Ms. Ashkenazi to the Audit Committee and the Ethics and Compliance Committee effective December 1, 2018. She will serve on the Audit Committee and the Ethics & Compliance Committee.